Credit Agricole’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$304 Hold
18
﹤0.01% 1251
2024
Q4
$332 Hold
18
﹤0.01% 1264
2024
Q3
$391 Hold
18
﹤0.01% 1267
2024
Q2
$353 Hold
18
﹤0.01% 1090
2024
Q1
$362 Hold
18
﹤0.01% 930
2023
Q4
$520 Hold
18
﹤0.01% 890
2023
Q3
$481 Hold
18
﹤0.01% 903
2023
Q2
$667 Hold
18
﹤0.01% 672
2023
Q1
$562 Hold
18
﹤0.01% 642
2022
Q4
$536 Hold
18
﹤0.01% 691
2022
Q3
$1K Hold
18
﹤0.01% 663
2022
Q2
$1K Hold
18
﹤0.01% 666
2022
Q1
$1K Buy
+18
New +$1.19K ﹤0.01% 691
2021
Q3
Sell
-10,000
Closed -$922K 692
2021
Q2
$922K Buy
+10,000
New +$798K 0.02% 265

Other funds holding FLGT

Credit Agricole's FLGT Position: Q1 2025 in Review

Credit Agricole held its Fulgent Genetics (FLGT) position steady in Q1 2025 at 18 shares worth $304. The position accounts for ﹤0.01% of the portfolio, ranked #1251.

Credit Agricole first reported a position in FLGT in Q2 2021 and has held it in 14 quarters since. The position peaked at $922K in Q2 2021. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Credit Agricole held 18 shares of Fulgent Genetics worth $304 as of Q1 2025.
  • Credit Agricole left its Fulgent Genetics share count unchanged in Q1 2025.
  • Fulgent Genetics made up ﹤0.01% of Credit Agricole's portfolio in Q1 2025, its #1251 holding.
  • Credit Agricole first reported a position in Fulgent Genetics in Q2 2021 and has held it in 14 quarters since.
  • Credit Agricole's Fulgent Genetics position peaked at $922K in Q2 2021.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.